Leukocyte behavior in angiogenic vessels is affected by tumor-derived nitric oxide.
D000818:Animals; D002448:Cell Adhesion; D004195:Disease Models, Animal; D004730:Endothelium, Vascular / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D019793:Fluorescein; D005456:Fluorescent Dyes; D006439:Hemodynamics / Q000502:physiology; D007962:Leukocytes / Q000502:physiology*; D008297:Male; D008643:Mesentery / Q000098:blood supply*; D008833:Microcirculation / Q000503:physiopathology; D018613:Microscopy, Confocal; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009389:Neovascularization, Pathologic / Q000473:pathology / Q000503:physiopathology*; D009569:Nitric Oxide / Q000378:metabolism / Q000502:physiology*; D010534:Peritoneal Neoplasms / Q000098:blood supply* / Q000503:physiopathology; D051381:Rats; D011916:Rats, Inbred F344
C414689:4,5-diaminofluorescein diacetate; D004791:Enzyme Inhibitors; D005456:Fluorescent Dyes; D009569:Nitric Oxide; D019793:Fluorescein; D019331:NG-Nitroarginine Methyl Ester